Entity Common Stock, Shares Outstanding of Apellis Pharmaceuticals, Inc. from 20 Dec 2017 to 17 Feb 2026
- Taxonomy & unit
- dei: shares
- Description
- Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
- Summary
-
Apellis Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 20 Dec 2017 to 17 Feb 2026.
- Apellis Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 17 Feb 2026 was 127,829,909, a 1.7% increase year-over-year.
- Source SEC data
- View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)
Apellis Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | 127,829,909 | +2,147,649 | +1.7% | 17 Feb 2026 | 10-K | 24 Feb 2026 | 2025 | FY |
| Q3 2025 | 126,525,218 | +2,132,201 | +1.7% | 23 Oct 2025 | 10-Q | 30 Oct 2025 | 2025 | Q3 |
| Q2 2025 | 126,289,910 | +4,523,582 | +3.7% | 24 Jul 2025 | 10-Q | 31 Jul 2025 | 2025 | Q2 |
| Q1 2025 | 125,682,260 | +4,316,705 | +3.6% | 30 Apr 2025 | 10-Q | 07 May 2025 | 2025 | Q1 |
| Q3 2024 | 124,393,017 | +5,893,072 | +5% | 29 Oct 2024 | 10-Q | 05 Nov 2024 | 2024 | Q3 |
| Q2 2024 | 121,766,328 | +4,029,039 | +3.4% | 25 Jul 2024 | 10-Q | 01 Aug 2024 | 2024 | Q2 |
| Q1 2024 | 121,365,555 | +4,908,547 | +4.2% | 01 May 2024 | 10-Q | 07 May 2024 | 2024 | Q1 |
| Q3 2023 | 118,499,945 | +7,924,398 | +7.2% | 24 Oct 2023 | 10-Q | 01 Nov 2023 | 2023 | Q3 |
| Q2 2023 | 117,737,289 | +7,871,984 | +7.2% | 24 Jul 2023 | 10-Q | 31 Jul 2023 | 2023 | Q2 |
| Q1 2023 | 116,457,008 | +9,935,190 | +9.3% | 01 May 2023 | 10-Q | 04 May 2023 | 2023 | Q1 |
| Q3 2022 | 110,575,547 | +23,280,176 | +27% | 01 Nov 2022 | 10-Q | 07 Nov 2022 | 2022 | Q3 |
| Q2 2022 | 109,865,305 | +22,862,020 | +26% | 04 Aug 2022 | 10-Q | 08 Aug 2022 | 2022 | Q2 |
| Q1 2022 | 106,521,818 | +26,025,047 | +32% | 29 Apr 2022 | 10-Q | 04 May 2022 | 2022 | Q1 |
| Q3 2021 | 87,295,371 | +11,558,447 | +15% | 02 Nov 2021 | 10-Q | 08 Nov 2021 | 2021 | Q3 |
| Q2 2021 | 87,003,285 | +11,399,294 | +15% | 03 Aug 2021 | 10-Q | 09 Aug 2021 | 2021 | Q2 |
| Q1 2021 | 80,496,771 | +4,983,707 | +6.6% | 23 Apr 2021 | 10-Q | 28 Apr 2021 | 2021 | Q1 |
| Q3 2020 | 75,736,924 | +11,848,686 | +19% | 28 Oct 2020 | 10-Q | 02 Nov 2020 | 2020 | Q3 |
| Q2 2020 | 75,603,991 | +11,908,474 | +19% | 27 Jul 2020 | 10-Q | 30 Jul 2020 | 2020 | Q2 |
| Q1 2020 | 75,513,064 | +12,280,588 | +19% | 24 Apr 2020 | 10-Q | 29 Apr 2020 | 2020 | Q1 |
| Q3 2019 | 63,888,238 | +7,645,667 | +14% | 01 Nov 2019 | 10-Q | 05 Nov 2019 | 2019 | Q3 |
| Q2 2019 | 63,695,517 | +7,517,393 | +13% | 24 Jul 2019 | 10-Q | 31 Jul 2019 | 2019 | Q2 |
| Q1 2019 | 63,232,476 | +12,859,714 | +26% | 30 Apr 2019 | 10-Q | 07 May 2019 | 2019 | Q1 |
| Q3 2018 | 56,242,571 | 05 Nov 2018 | 10-Q | 13 Nov 2018 | 2018 | Q3 | ||
| Q2 2018 | 56,178,124 | 20 Jul 2018 | 10-Q | 31 Jul 2018 | 2018 | Q2 | ||
| Q1 2018 | 50,372,762 | 12 Mar 2018 | 10-K | 19 Mar 2018 | 2017 | FY | ||
| Q4 2017 | 50,334,152 | 20 Dec 2017 | 10-Q | 20 Dec 2017 | 2017 | Q3 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.